HomeBOT • ASX
add
Botanix Pharmaceuticals Ltd
Nakaraang pagsara
$0.047
Sakop ng taon
$0.045 - $0.49
Market cap
102.17M AUD
Average na Volume
14.41M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 8.25M | 4,271.29% |
Gastos sa pagpapatakbo | 22.08M | 41.82% |
Net na kita | -16.60M | -7.47% |
Net profit margin | -201.11 | 97.54% |
Kita sa bawat share | — | — |
EBITDA | -16.22M | -5.12% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 31.61M | -34.73% |
Kabuuang asset | 98.57M | -0.88% |
Kabuuang sagutin | 44.58M | 540.50% |
Kabuuang equity | 54.00M | — |
Natitirang share | 1.97B | — |
Presyo para makapag-book | 1.57 | — |
Return on assets | -42.63% | — |
Return on capital | -76.30% | — |
Cash Flow
Net change in cash
| (AUD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -16.60M | -7.47% |
Cash mula sa mga operasyon | -15.14M | 0.95% |
Cash mula sa pag-invest | -220.81K | 48.29% |
Cash mula sa financing | -1.28M | -738.08% |
Net change in cash | -16.68M | -8.04% |
Malayang cash flow | -7.24M | -58.36% |
Tungkol
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Itinatag
1984
Website
Mga Empleyado
11
